194 related articles for article (PubMed ID: 29463369)
21. Regulation of demethylation and re-expression of RASSF1A gene in hepatocellular carcinoma cell lines treated with NCTD in vitro.
Wang Y; Xu M; Di ZH; Zhang J; Mao XQ; Sun HB
J Cancer Res Ther; 2015; 11(4):818-22. PubMed ID: 26881524
[TBL] [Abstract][Full Text] [Related]
22. Codelivery of Doxorubicin and shAkt1 by Poly(ethylenimine)-Glycyrrhetinic Acid Nanoparticles To Induce Autophagy-Mediated Liver Cancer Combination Therapy.
Wang FZ; Xing L; Tang ZH; Lu JJ; Cui PF; Qiao JB; Jiang L; Jiang HL; Zong L
Mol Pharm; 2016 Apr; 13(4):1298-307. PubMed ID: 26894988
[TBL] [Abstract][Full Text] [Related]
23. Glycyrrhetinic acid-functionalized mesoporous silica nanoparticles as hepatocellular carcinoma-targeted drug carrier.
Lv Y; Li J; Chen H; Bai Y; Zhang L
Int J Nanomedicine; 2017; 12():4361-4370. PubMed ID: 28652738
[TBL] [Abstract][Full Text] [Related]
24. Paclitaxel-loaded nanoparticles decorated with bivalent fragment HAb18 F(ab')
Jin C; Bai L; Lin L; Wang S; Yin X
Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1076-1084. PubMed ID: 28776396
[TBL] [Abstract][Full Text] [Related]
25. Cantharidin exerts anti-hepatocellular carcinoma by miR-214 modulating macrophage polarization.
Lu S; Gao Y; Huang X; Wang X
Int J Biol Sci; 2014; 10(4):415-25. PubMed ID: 24719559
[TBL] [Abstract][Full Text] [Related]
26. Preparation, characterization and anticancer activity of norcantharidin-loaded poly(ethylene glycol)-poly(caprolactone) amphiphilic block copolymer micelles.
Chen SF; Lu WF; Wen ZY; Li Q; Chen JH
Pharmazie; 2012 Sep; 67(9):781-8. PubMed ID: 23016451
[TBL] [Abstract][Full Text] [Related]
27. In Vitro and In Vivo Evaluation of SP94 Modified Liposomes Loaded with N-14NCTDA, a Norcantharimide Derivative for Hepatocellular Carcinoma-Targeting.
Jiang Y; Liu X; Tan X; Hou Y; Sun W; Gou J; Yin T; He H; Zhang Y; Tang X
AAPS PharmSciTech; 2020 Oct; 21(7):277. PubMed ID: 33033942
[TBL] [Abstract][Full Text] [Related]
28. Norcantharidin combined with Coix seed oil synergistically induces apoptosis and inhibits hepatocellular carcinoma growth by downregulating regulatory T cells accumulation.
Wang D; Yang C; Wang Z; Yang Y; Li D; Ding X; Xu W; Zheng Q
Sci Rep; 2017 Aug; 7(1):9373. PubMed ID: 28839202
[TBL] [Abstract][Full Text] [Related]
29. Promising positive liver targeting delivery system based on arabinogalactan-anchored polymeric micelles of norcantharidin.
Zhang Z; Yang L; Hou J; Xia X; Wang J; Ning Q; Jiang S
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S630-S640. PubMed ID: 30449176
[TBL] [Abstract][Full Text] [Related]
30. Norcantharidin inhibits IL-6-induced epithelial‑mesenchymal transition via the JAK2/STAT3/TWIST signaling pathway in hepatocellular carcinoma cells.
Gao Y; Li W; Liu R; Guo Q; Li J; Bao Y; Zheng H; Jiang S; Hua B
Oncol Rep; 2017 Aug; 38(2):1224-1232. PubMed ID: 28677802
[TBL] [Abstract][Full Text] [Related]
31. [Effects of interventional therapy with norcantharidin microsphere on hepatoma in rats and its mechanism].
Li Q; Fan ZZ; Li XQ; Liu XH; Sun J; Gu W; Heng P; Gao H
Zhong Xi Yi Jie He Xue Bao; 2006 Jul; 4(4):378-83. PubMed ID: 16834975
[TBL] [Abstract][Full Text] [Related]
32. Norcantharidin-Encapsulated C60-Modified Nanomicelles: A Potential Approach to Mitigate Cytotoxicity in Renal Cells and Simultaneously Enhance Anti-Tumor Activity in Hepatocellular Carcinoma Cells.
Ding Z; Xu B; Zhang H; Wang Z; Sun L; Tang M; Ding M; Zhang T; Shi S
Molecules; 2023 Nov; 28(22):. PubMed ID: 38005331
[TBL] [Abstract][Full Text] [Related]
33. Metal-organic framework IRMOFs coated with a temperature-sensitive gel delivering norcantharidin to treat liver cancer.
Li XY; Guan QX; Shang YZ; Wang YH; Lv SW; Yang ZX; Wang R; Feng YF; Li WN; Li YJ
World J Gastroenterol; 2021 Jul; 27(26):4208-4220. PubMed ID: 34326620
[TBL] [Abstract][Full Text] [Related]
34. Norcantharidin inhibits growth of human gallbladder carcinoma xenografted tumors in nude mice by inducing apoptosis and blocking the cell cycle in vivo.
Fan YZ; Zhao ZM; Fu JY; Chen CQ; Sun W
Hepatobiliary Pancreat Dis Int; 2010 Aug; 9(4):414-22. PubMed ID: 20688607
[TBL] [Abstract][Full Text] [Related]
35. Targeted delivery of microRNA-199a-3p using self-assembled dipeptide nanoparticles efficiently reduces hepatocellular carcinoma in mice.
Varshney A; Panda JJ; Singh AK; Yadav N; Bihari C; Biswas S; Sarin SK; Chauhan VS
Hepatology; 2018 Apr; 67(4):1392-1407. PubMed ID: 29108133
[TBL] [Abstract][Full Text] [Related]
36. Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin.
Zhang X; Li J; Yan M
Drug Dev Ind Pharm; 2016 Oct; 42(10):1590-9. PubMed ID: 26942448
[TBL] [Abstract][Full Text] [Related]
37. Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs.
Zhang L; Yao J; Zhou J; Wang T; Zhang Q
Int J Pharm; 2013 Jan; 441(1-2):654-64. PubMed ID: 23117024
[TBL] [Abstract][Full Text] [Related]
38. Studies on anti-hepatocarcinoma effect, pharmacokinetics and tissue distribution of carboxymethyl chitosan based norcantharidin conjugates.
Chi J; Jiang Z; Chen X; Peng Y; Liu W; Han B; Han B
Carbohydr Polym; 2019 Dec; 226():115297. PubMed ID: 31582090
[TBL] [Abstract][Full Text] [Related]
39. Glycyrrhetinic Acid Mediated Drug Delivery Carriers for Hepatocellular Carcinoma Therapy.
Cai Y; Xu Y; Chan HF; Fang X; He C; Chen M
Mol Pharm; 2016 Mar; 13(3):699-709. PubMed ID: 26808002
[TBL] [Abstract][Full Text] [Related]
40. Preparation and pharmacological evaluation of norcantharidin-conjugated carboxymethyl chitosan in mice bearing hepatocellular carcinoma.
Jiang Z; Chi J; Han B; Liu W
Carbohydr Polym; 2017 Oct; 174():282-290. PubMed ID: 28821069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]